Redmile Group, LLC
- SEC CIK
- 0001425738
- Latest filing
- Aug 14, 2026
Holdings in Q3 2021
Holdings as of Sep 30, 2021, filed Nov 15, 2021. Long positions only; changes compare share counts with Q2 2021.
- Positions
- 75
- −11 vs. Q2 2021
- Portfolio value
- $5.73B
- −$1.02B (−15.2%) vs. Q2 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| FATEFate Therapeutics Inc | COM | 12,957,222 | $768.0M | 13.4% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 2,131,796 | $225.7M | 3.9% | −85,200−3.8% | Reduced | History |
| IGMSIGM Biosciences, Inc. | COM | 3,425,455 | $225.3M | 3.9% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 730,582 | $220.6M | 3.8% | −59,700−7.6% | Reduced | History |
| ADCTADC Therapeutics SA | SHS | 7,529,329 | $204.5M | 3.6% | +7,300+0.1% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 20,799,303 | $198.6M | 3.5% | 00.0% | Unchanged | History |
| SKINSkinHealth Systems Inc. | COM CL A | 7,483,706 | $194.4M | 3.4% | +1,130,460+17.8% | Added | History |
| LIVNLivaNova PLC | SHS | 2,191,019 | $173.5M | 3.0% | +1,079,335+97.1% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 1,975,006 | $171.8M | 3.0% | −77,500−3.8% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 3,043,298 | $164.3M | 2.9% | +31,217+1.0% | Added | History |
| KYMRKymera Therapeutics, Inc. | COM | 2,793,708 | $164.1M | 2.9% | +262,200+10.4% | Added | History |
| NVTAInvitae Corp | COM | 5,317,477 | $151.2M | 2.6% | +670,084+14.4% | Added | History |
| IVVDInvivyd, Inc. | COM | 3,246,960 | $137.2M | 2.4% | +3,246,960 | New | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 4,031,521 | $137.0M | 2.4% | −213,200−5.0% | Reduced | History |
| REPLReplimune Group, Inc. | COM | 4,078,112 | $120.9M | 2.1% | −113,400−2.7% | Reduced | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 6,466,277 | $115.7M | 2.0% | +16,700+0.3% | Added | History |
| STTKShattuck Labs, Inc. | COM | 5,619,914 | $114.5M | 2.0% | 00.0% | Unchanged | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 861,401 | $112.2M | 2.0% | +1,300+0.2% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 1,982,432 | $103.5M | 1.8% | −89,700−4.3% | Reduced | History |
| SGENSeagen Inc. | COM | 587,374 | $99.7M | 1.7% | −184,011−23.9% | Reduced | History |
| ABSIAbsci Corp | COM | 8,031,094 | $93.4M | 1.6% | +8,031,094 | New | History |
| NRIXNurix Therapeutics, Inc. | COM | 3,093,077 | $92.7M | 1.6% | −97,000−3.0% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 1,869,030 | $87.8M | 1.5% | −67,500−3.5% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,550,205 | $84.2M | 1.5% | +243,177+10.5% | Added | History |
| RGNXREGENXBIO Inc. | COM | 2,008,001 | $84.2M | 1.5% | −130,200−6.1% | Reduced | History |
| OSHOak Street Health, Inc. | COM | 1,878,520 | $79.9M | 1.4% | −424,133−18.4% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 2,567,696 | $67.4M | 1.2% | −56,700−2.2% | Reduced | History |
| PRTAProthena Corp Public Ltd Co | SHS | 901,491 | $64.2M | 1.1% | −314,166−25.8% | Reduced | History |
| ALXOAlx Oncology Holdings Inc | COM | 864,435 | $63.8M | 1.1% | −49,600−5.4% | Reduced | History |
| NVRONevro Corp | COM | 542,932 | $63.2M | 1.1% | −51,800−8.7% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 3,349,185 | $62.3M | 1.1% | −75,853−2.2% | Reduced | History |
| STOKStoke Therapeutics, Inc. | COM | 2,381,958 | $60.6M | 1.1% | −76,600−3.1% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 2,687,444 | $60.1M | 1.0% | −117,500−4.2% | Reduced | History |
| NGMNGM Biopharmaceuticals Inc | COM | 2,505,118 | $52.7M | 0.9% | −287,330−10.3% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 3,083,501 | $52.0M | 0.9% | −72,900−2.3% | Reduced | History |
| ICUIIcu Medical Inc | COM | 222,526 | $51.9M | 0.9% | −403−0.2% | Reduced | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 3,972,270 | $49.2M | 0.9% | +3,972,270 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 1,120,388 | $49.0M | 0.9% | −107,200−8.7% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 127,502 | $47.5M | 0.8% | +18,701+17.2% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 120,710 | $47.2M | 0.8% | +26,245+27.8% | Added | History |
| IMGNImmunoGen, Inc. | COM | 8,258,345 | $46.8M | 0.8% | −622,600−7.0% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 4,541,009 | $45.1M | 0.8% | 00.0% | Unchanged | History |
| EPZMEpizyme, Inc. | COM | 7,458,660 | $38.2M | 0.7% | −1,056,400−12.4% | Reduced | History |
| MDVLMedAvail Holdings, Inc. | COM | 11,724,726 | $34.2M | 0.6% | 00.0% | Unchanged | History |
| TCRRTCR2 Therapeutics Inc. | COM | 3,816,709 | $32.5M | 0.6% | +580,900+18.0% | Added | History |
| GRTSGritstone bio, Inc. | COM | 2,821,085 | $30.5M | 0.5% | +594,879+26.7% | Added | History |
| STVNStevanato Group S.p.A. | ORD SHS | 1,187,025 | $30.0M | 0.5% | +1,187,025 | New | History |
| ZYMEZymeworks Inc. | COM | 882,097 | $25.6M | 0.4% | −57,600−6.1% | Reduced | History |
| NGNENeurogene Inc. | COM | 3,507,235 | $25.4M | 0.4% | −412,000−10.5% | Reduced | History |
| IMTXImmatics N.V. | SHS | 1,941,892 | $25.2M | 0.4% | 00.0% | Unchanged | History |
| RCELAVITA Medical, Inc. | COM | 1,346,217 | $23.9M | 0.4% | −64,900−4.6% | Reduced | History |
| AMEDAmedisys Inc | COM | 150,376 | $22.4M | 0.4% | +17,918+13.5% | Added | History |
| BVSBioventus Inc. | COM CL A | 1,489,856 | $21.1M | 0.4% | +2,900+0.2% | Added | History |
| KLRSKalaris Therapeutics, Inc. | COM | 836,912 | $21.0M | 0.4% | −747,181−47.2% | Reduced | History |
| Dynamics Special Purpose Cor268010105 | CLASS A COM | 1,924,900 | $19.1M | 0.3% | −88,000−4.4% | Reduced | – |
| TKNOAlpha Teknova, Inc. | COM | 725,000 | $18.0M | 0.3% | 00.0% | Unchanged | History |
| LFSTLifeStance Health Group, Inc. | COM | 1,222,408 | $17.7M | 0.3% | −34,659−2.8% | Reduced | History |
| LVTXLAVA Therapeutics NV | SHS | 2,816,196 | $16.7M | 0.3% | 00.0% | Unchanged | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 2,088,089 | $16.3M | 0.3% | 00.0% | Unchanged | – |
| ZGNXZogenix, Inc. | COM NEW | 1,014,414 | $15.4M | 0.3% | +1,014,414 | New | History |
| ONEM1Life Healthcare Inc | COM | 600,432 | $12.2M | 0.2% | −1,066,531−64.0% | Reduced | History |
| PROFProfound Medical Corp. | COM NEW | 787,346 | $11.5M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,844,305 | $10.9M | 0.2% | −11,900−0.6% | Reduced | History |
| STXSStereotaxis, Inc. | COM NEW | 1,855,504 | $9.98M | 0.2% | 00.0% | Unchanged | History |
| CTSOCytosorbents Corp | COM NEW | 1,044,434 | $8.48M | 0.1% | −259,935−19.9% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 696,377 | $8.47M | 0.1% | −10.0% | Reduced | History |
| Itamar Med Ltd465437101 | SPONSORED ADS | 264,600 | $8.00M | 0.1% | −590,300−69.0% | Reduced | – |
| AYLAOld Ayala, Inc | COM | 667,816 | $7.57M | 0.1% | 00.0% | Unchanged | History |
| BCELAtreca, Inc. | CL A COM | 1,170,006 | $7.29M | 0.1% | −1,290,262−52.4% | Reduced | History |
| APREAprea Therapeutics, Inc. | COM | 694,918 | $3.55M | 0.1% | 00.0% | Unchanged | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 1,358,825 | $3.33M | 0.1% | 00.0% | Unchanged | History |
| KAKineta, Inc. | COM | 59,487 | $614.0K | <0.1% | 00.0% | Unchanged | History |
| TCDATricida, Inc. | COM | 54,758 | $254.0K | <0.1% | 00.0% | Unchanged | History |
| SYRSSyros Pharmaceuticals, Inc. | COM | 38,912 | $174.0K | <0.1% | 00.0% | Unchanged | History |
| OVIDOvid Therapeutics Inc. | COM | 40,674 | $137.0K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q2 2021 (16)
Positions held at the end of Q2 2021 that are gone from this filing.
| Security | Class | Shares in Q2 2021 | Value in Q2 2021 | % of portfolio in Q2 2021 | History |
|---|---|---|---|---|---|
| DXCMDexcom Inc | COM | 230,558 | $98.4M | 1.5% | History |
| ZYZymergen Inc. | COM | 1,522,900 | $60.9M | 0.9% | History |
| SLQTSelectQuote, Inc. | COM | 2,411,957 | $46.5M | 0.7% | History |
| CRLCharles River Laboratories International, Inc. | COM | 108,374 | $40.1M | 0.6% | History |
| CICigna Group | Stock | 159,727 | $37.9M | 0.6% | History |
| CTLTCatalent, Inc. | COM | 310,111 | $33.5M | 0.5% | History |
| ARDXArdelyx, Inc. | COM | 3,714,100 | $28.2M | 0.4% | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 425,480 | $22.6M | 0.3% | History |
| PPDPPD, Inc. | COM | 466,471 | $21.5M | 0.3% | History |
| QSIQuantum-Si Inc | COM CL A | 1,700,000 | $20.8M | 0.3% | History |
| INNVInnovAge Holding Corp. | COM | 843,578 | $18.0M | 0.3% | History |
| QTRXQuanterix Corp | COM | 240,933 | $14.1M | 0.2% | History |
| TMCITreace Medical Concepts, Inc. | COM | 323,765 | $10.1M | 0.1% | History |
| STIMNeuronetics, Inc. | COM | 394,355 | $6.32M | 0.1% | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 237,360 | $5.10M | 0.1% | History |
| TLISTalis Biomedical Corp | COM | 363,849 | $4.01M | 0.1% | History |